Search research articles
Contact Us
Filters
Showing results (51-60 of 149) with videos related to
Page
of 15
Sort By:
International Journal of Molecular Sciences
|
March 6, 2021
PRKAR1B-AS2 Long Noncoding RNA Promotes Tumorigenesis, Survival, and Chemoresistance via the PI3K/AKT/mTOR Pathway
Abdelrahman M Elsayed, Emine Bayraktar, Paola Amero, et al.
Molecular Cancer Therapeutics
|
June 6, 2020
NRG1/ERBB3 Pathway Activation Induces Acquired Resistance to XPO1 Inhibitors
Takahito M Miyake, Sunila Pradeep, Emine Bayraktar, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
March 25, 2020
Long-term Efficacy and Tolerability of RPC4046 in an Open-Label Extension Trial of Patients With Eosinophilic Esophagitis
Evan S Dellon, Margaret H Collins, Marc E Rothenberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 8, 2018
Paclitaxel Sensitivity of Ovarian Cancer Can be Enhanced by Knocking Down Pairs of Kinases that Regulate MAP4 Phosphorylation and Microtubule Stability
Hailing Yang, Weiqun Mao, Cristian Rodriguez-Aguayo, et al.
Plos One
|
October 27, 2011
Neuropilin-2 mediated β-catenin signaling and survival in human gastro-intestinal cancer cell lines
Shaija Samuel, Puja Gaur, Fan Fan, et al.
Cancers
|
June 2, 2021
Inactivating Mutations of the <i>IK</i> Gene Weaken Ku80/Ku70-Mediated DNA Repair and Sensitize Endometrial Cancer to Chemotherapy
Chao Gao, Guangxu Jin, Elizabeth Forbes, et al.
The Journal of Pathology
|
September 18, 2014
MiR-506 inhibits multiple targets in the epithelial-to-mesenchymal transition network and is associated with good prognosis in epithelial ovarian cancer
Yan Sun, Limei Hu, Hong Zheng, et al.
Carcinogenesis
|
January 1, 2014
EDD enhances cell survival and cisplatin resistance and is a therapeutic target for epithelial ovarian cancer
Amber Bradley, Hui Zheng, Angela Ziebarth, et al.
Oncotarget
|
August 6, 2020
Therapeutic efficacy of liposomal Grb2 antisense oligodeoxynucleotide (L-Grb2) in preclinical models of ovarian and uterine cancer
Olivia D Lara, Emine Bayraktar, Paola Amero, et al.
Oncotarget
|
February 27, 2016
Therapeutic evaluation of microRNA-15a and microRNA-16 in ovarian cancer
Shailendra Kumar Dhar Dwivedi, Soumyajit Banerjee Mustafi, Lingegowda S Mangala, et al.
Page
of 15
Search research articles
Search
Showing results (51-60 of 149) with videos related to
Sort By:
Page
of 15
International Journal of Molecular Sciences
|
March 6, 2021
PRKAR1B-AS2 Long Noncoding RNA Promotes Tumorigenesis, Survival, and Chemoresistance via the PI3K/AKT/mTOR Pathway
Abdelrahman M Elsayed, Emine Bayraktar, Paola Amero, et al.
Molecular Cancer Therapeutics
|
June 6, 2020
NRG1/ERBB3 Pathway Activation Induces Acquired Resistance to XPO1 Inhibitors
Takahito M Miyake, Sunila Pradeep, Emine Bayraktar, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
March 25, 2020
Long-term Efficacy and Tolerability of RPC4046 in an Open-Label Extension Trial of Patients With Eosinophilic Esophagitis
Evan S Dellon, Margaret H Collins, Marc E Rothenberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 8, 2018
Paclitaxel Sensitivity of Ovarian Cancer Can be Enhanced by Knocking Down Pairs of Kinases that Regulate MAP4 Phosphorylation and Microtubule Stability
Hailing Yang, Weiqun Mao, Cristian Rodriguez-Aguayo, et al.
Plos One
|
October 27, 2011
Neuropilin-2 mediated β-catenin signaling and survival in human gastro-intestinal cancer cell lines
Shaija Samuel, Puja Gaur, Fan Fan, et al.
Cancers
|
June 2, 2021
Inactivating Mutations of the <i>IK</i> Gene Weaken Ku80/Ku70-Mediated DNA Repair and Sensitize Endometrial Cancer to Chemotherapy
Chao Gao, Guangxu Jin, Elizabeth Forbes, et al.
The Journal of Pathology
|
September 18, 2014
MiR-506 inhibits multiple targets in the epithelial-to-mesenchymal transition network and is associated with good prognosis in epithelial ovarian cancer
Yan Sun, Limei Hu, Hong Zheng, et al.
Carcinogenesis
|
January 1, 2014
EDD enhances cell survival and cisplatin resistance and is a therapeutic target for epithelial ovarian cancer
Amber Bradley, Hui Zheng, Angela Ziebarth, et al.
Oncotarget
|
August 6, 2020
Therapeutic efficacy of liposomal Grb2 antisense oligodeoxynucleotide (L-Grb2) in preclinical models of ovarian and uterine cancer
Olivia D Lara, Emine Bayraktar, Paola Amero, et al.
Oncotarget
|
February 27, 2016
Therapeutic evaluation of microRNA-15a and microRNA-16 in ovarian cancer
Shailendra Kumar Dhar Dwivedi, Soumyajit Banerjee Mustafi, Lingegowda S Mangala, et al.
Page
of 15